PharmaFlow in October: Deal making picks up; Pharma companies invest in capacity building
The year
2018 has witnessed a record-setting pace in approvals of new drugs. By early
November, th
Trumpcare receives a blow; EMA to suspend 300 drugs due to clinical data integrity violations in India
This week, Phispers takes you to the US, where President Trump’s efforts to repeal and replace